Search Results - "Rodrigues, Angelica Nogueira"
-
1
Tailoring Endometrial Cancer Treatment Based on Molecular Pathology: Current Status and Possible Impacts on Systemic and Local Treatment
Published in International journal of molecular sciences (15-07-2024)“…Endometrial cancer (EC) is a heterogeneous disease with a rising incidence worldwide. The understanding of its molecular pathways has evolved substantially…”
Get full text
Journal Article -
2
Mutation screening of TP53, CHEK2 and BRCA genes in patients at high risk for hereditary breast and ovarian cancer (HBOC) in Brazil
Published in Breast cancer (Tokyo, Japan) (01-05-2019)“…Background Few studies related to hereditary breast and ovarian cancer syndrome (HBOC) have been conducted in Brazil, and they are restricted to only small…”
Get full text
Journal Article -
3
Barriers to Primary Debulking Surgery for Advanced Ovarian Cancer in Latin America
Published in International journal of gynecological cancer (01-10-2017)“…Ovarian cancer is gynecologic tumor with particularly high mortality because it is usually diagnosed in advanced stages. In Latin America and the Caribbean, it…”
Get more information
Journal Article -
4
Optimizing treatment selection and sequencing decisions for first-line maintenance therapy of newly diagnosed advanced ovarian cancer – International considerations amongst upper middle- and high-income countries (UMIC and HIC)
Published in Gynecologic oncology reports (01-08-2022)“…The incidence and mortality rates of ovarian cancer are increasing globally. Ovarian cancer is diagnosed at an advanced stage in 80% of women. After standard,…”
Get full text
Journal Article -
5
Immunohistochemical WWOX Expression and Association with Angiogenesis, p53 Expression, Cell Proliferation and Clinicopathological Parameters in Cervical Cancer
Published in Revista Brasileira de ginecologia e obstetrícia (01-02-2018)“…The current study evaluated the expression of WW domain-containing oxidoreductase (WWOX), its association with clinicopathological features and with p53, Ki-67…”
Get full text
Journal Article -
6
Primary results from CECILIA, a global single-arm phase II study evaluating bevacizumab, carboplatin and paclitaxel for advanced cervical cancer
Published in Gynecologic oncology (01-10-2020)“…Adding bevacizumab to cisplatin–paclitaxel for advanced cervical cancer significantly improves overall and progression-free survival. We evaluated bevacizumab…”
Get full text
Journal Article -
7
Challenges in the diagnosis and treatment of gestational trophoblastic neoplasia worldwide
Published in World journal of clinical oncology (24-02-2019)“…Gestational trophoblastic neoplasia (GTN) is a rare tumor that originates from pregnancy that includes invasive mole, choriocarcinoma (CCA), placental site…”
Get full text
Journal Article -
8
Impact of COVID-19 pandemic among patients with lung and head and neck cancer assisted in a public cancer center in Brazil
Published in BMC cancer (29-04-2024)“…There is no updated national data regarding the real impact of the COVID-19 pandemic on delaying diagnosis and treatment among patients with lung, and head,…”
Get full text
Journal Article -
9
Editorial: Cervical cancer control in Latin America and the Caribbean
Published in Frontiers in oncology (08-05-2024)Get full text
Journal Article -
10
Phase 2 trial of erlotinib combined with cisplatin and radiotherapy in patients with locally advanced cervical cancer
Published in Cancer (15-04-2014)“…BACKGROUND Cisplatin‐based chemoradiation (CRT) is the standard treatment for patients with locally advanced cervical cancer. Epidermal growth factor receptor…”
Get full text
Journal Article -
11
An alert to Latin America: Current human papillomavirus vaccination trends highlight key barriers to successful implementation
Published in Cancer (15-06-2017)“…Human papillomavirus vaccine programs run the risk of repeating the problems associated with Papanicolaou testing programs in low‐income and middle‐income…”
Get full text
Journal Article -
12
Factors influencing COVID-19 mortality among cancer patients: A Brazilian multi-institutional study
Published in PloS one (21-12-2023)“…This study aimed to describe the demographic and clinical characteristics of cancer patients with COVID-19, exploring factors associated with adverse outcomes…”
Get full text
Journal Article -
13
Efficacy of Dexrazoxane in Preventing Anthracycline Cardiotoxicity in Breast Cancer
Published in JACC CardioOncology (01-09-2019)“…The authors performed a systematic review and meta-analysis of randomized and nonrandomized trials on the efficacy of dexrazoxane in patients with breast…”
Get full text
Journal Article -
14
A demographic and clinical panorama of a sixteen-year cohort of soft tissue sarcoma patients in Brazil
Published in Scientific reports (18-11-2021)“…Little is known about soft tissue sarcomas (STS) in Brazil, once the federal statistics regarding estimates on incidence and mortality of the most common…”
Get full text
Journal Article -
15
Cervical cancer control in Latin America: A call to action
Published in Cancer (15-02-2016)“…Cervical cancer (CC) is second most common cause of cancer in Latin America and is a leading cause of cancer mortality among women. In 2015, an estimated…”
Get full text
Journal Article -
16
Recommendations for Advancing the Diagnosis and Management of Hereditary Breast and Ovarian Cancer in Brazil
Published in JCO global oncology (01-11-2020)“…The objective of this review was to address the barriers limiting access to genetic cancer risk assessment and genetic testing for individuals with suspected…”
Get full text
Journal Article -
17
HPV vaccination in Latin America: Coverage status, implementation challenges and strategies to overcome it
Published in Frontiers in oncology (26-10-2022)“…Cervical cancer remains a leading cause of morbidity and mortality amongst females in Latin America (LATAM). Cervical cancer is a preventable disease and HPV…”
Get full text
Journal Article -
18
-
19
Recommendations for the prevention, screening, diagnosis, staging, and management of cervical cancer in areas with limited resources: Report from the International Gynecological Cancer Society consensus meeting
Published in Frontiers in oncology (18-08-2022)“…Introduction Nearly 85% of cervical cancer new cases are diagnosed in limited resources countries. Although several strategies have been proposed to reduce the…”
Get full text
Journal Article -
20
Recommendations for the treatment of vulvar cancer in settings with limited resources: Report from the International Gynecological Cancer Society consensus meeting
Published in Frontiers in oncology (20-09-2022)“…Introduction Due to scant literature and the absence of high-level evidence, the treatment of vulvar cancer is even more challenging in countries facing…”
Get full text
Journal Article